Stephen John Clarke

17PUBLICATIONS
99CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingSolid tumoursHaematological tumoursNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 27, 2026
Cost-effectiveness of first-line pembrolizumab monotherapy in PD-L1-high metastatic non-small cell lung cancer in Australia: evidence from trials and real-world practice.

|Apr 08, 2026
Cost-effectiveness of pembrolizumab plus chemotherapy for metastatic non-small cell lung cancer: a head-to-head trial vs. real-world comparison.

Srinivas Teppala, Juhee Koo, Stephen Clarke

|Mar 30, 2026
Impact of Symptom Phenotype on Surgical Quality and Survival in Small-Bowel Neuroendocrine Tumours: A Quality Metrics Analysis.

Siddharth Darbhamulla, Krishna Kotecha, David L Chan

|Jan 21, 2026
Real-World Outcomes of Pembrolizumab Monotherapy in Metastatic Non-Small Cell Lung Cancer by Age and Sex: A National Population-Based Study in Australia.

Chin Hang Yiu, Stephen J Clarke, Christine Y Lu

|Jan 06, 2026
Hemopurifier device in patients with solid tumours who have stable or progressive disease while on a treatment that includes pembrolizumab or nivolumab: protocol for an Australian safety, feasibility and dose-finding study.

Michael P Brown, Marco Matos, Stephen Clarke

|Nov 26, 2024
MuscleMap: An Open-Source, Community-Supported Consortium for Whole-Body Quantitative MRI of Muscle.

Marnee J McKay, Kenneth A Weber, Evert O Wesselink

Pageof 3

Frequent Collaborators

3 joint publications

Luis Vitetta

3 joint publications

Christine Y Lu

2 joint publications

Joseph Chung Yan Chan

2 joint publications

Justin Jee